Last week saw a number of broker notes hitting the wires once again. Three buy ratings that caught my eye are summarised below.
Here’s why brokers think investors ought to buy them next week:
According to a note out of UBS, its analysts have retained their buy rating and lifted their price target on this payments company’s shares to $6.20. The broker made the move after EML announced the acquisition of Sentenial. It notes that Sentenial’s Nuapay open banking business is well-placed in the European market and has opportunities to expand globally. UBS also likes that the deal further reduces its earnings exposure to giftcards. The EML share price was fetching $5.75 at the close of play on Friday afternoon.